The Dutch API and materials manufacturer DSM has licensed a series of biodegradable polymers from US firm MediVas for use in drug delivery applications. DSM's licence involves use of the polymers in t
The advent of drug-eluting stents has increased the partnering visibility for companies with biocoatings. Ten years ago, SurModics Inc. , one of the few sizeable "pure play" companies in the biocoa